𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Off-Label Use of Biologic Agents in the Treatment of Dermatosis, Part 2: Etanercept, Efalizumab, Alefacept, Rituximab, Daclizumab, Basiliximab, Omalizumab, and Cetuximab

✍ Scribed by G. Guhl; B. Díaz-Ley; J. Fernández-Herrera


Book ID
119627739
Publisher
Elsevier Science
Year
2008
Tongue
Spanish
Weight
579 KB
Volume
99
Category
Article
ISSN
0001-7310

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES